Prognostic significance of elevated troponin i after percutaneous coronary intervention
Authors:
- Warren J CantorWCWarren J Cantor
- L.KRistin NewbyLNL.KRistin Newby
- Robert H ChristensonRCRobert H Christenson
- Robert H TuttleRTRobert H Tuttle
- Vic HasselbladVHVic Hasselblad
- Paul W ArmstrongPAPaul W Armstrong
- David J MoliternoDMDavid J Moliterno
- Robert M CaliffRCRobert M Califf
- Eric J TopolETEric J Topol
- E.MAgnus OhmanEOE.MAgnus Ohman
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Troponisms, Necrosettes, Enzyme Leaks, Creatinine Phosphokinase Bumps, and InfarctletsCirculation, 2001
- Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous InterventionCirculation, 2001
- Randomized Trial of Aspirin, Sibrafiban, or Both for Secondary Prevention After Acute Coronary SyndromesCirculation, 2001
- Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trialThe Lancet, 2000
- Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events post-acute cOroNary sYndromes (SYMPHONY) trialAmerican Heart Journal, 1999
- Myonecrosis After Revascularization ProceduresJACC, 1998
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Significance of cardiac troponin T release after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1995
- Side-branch occlusion during percutaneous transluminal coronary angioplastyThe Lancet, 1992